Eli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.
LLY is increasing its manufacturing capacity in the United States by building four new plants. AZN's phase III study on camizestrant meets primary endpoint.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback